PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 67 filers reported holding PASSAGE BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $125 | -15.0% | 130,188 | +21.9% | 0.01% | -33.3% |
| Q4 2022 | $147 | -99.9% | 106,836 | +25.4% | 0.02% | +28.6% |
| Q3 2022 | $106,000 | -50.0% | 85,196 | -5.0% | 0.01% | -56.2% |
| Q2 2022 | $212,000 | +0.5% | 89,704 | +31.8% | 0.03% | +14.3% |
| Q1 2022 | $211,000 | +43.5% | 68,039 | +194.7% | 0.03% | +55.6% |
| Q4 2021 | $147,000 | -32.9% | 23,086 | +5.0% | 0.02% | -18.2% |
| Q3 2021 | $219,000 | – | 21,979 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |